Picture of Immunovia AB (publ) logo

IMMNOV Immunovia AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Immunovia Says CMS Sets Prelim Price Of $897 For Pancreasure Test

Sept 11 (Reuters) - Immunovia AB (publ) IMMNOV.ST:

CMS SETS PRELIMINARY PRICE OF $897 FOR PANCREASURE TEST

CMS FINAL PAYMENT DECISION EXPECTED NOVEMBER, EFFECTIVE JAN 2026

Source text: ID:nMFN2TJzMG

Further company coverage: IMMNOV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Immunovia AB (publ)

See all news